Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

Presentation TCT 2025

The Inflammatory Core of Coronary Artery Disease

Presenter: Dominick J. Angiolillo

October 26, 2025

Presentation TCT 2024

Debate Con: Never

Presenter: Dominick Angiolillo

October 30, 2024

Presentation TCT 2024

Optimal Anti-Thrombotic Therapy in Acute MI

Presenter: Dominick Angiolillo

October 29, 2024

Presentation TCT 2023

Update on Current Treatment Targets for Secondary Prevention

Presenter: Dominick Angiolillo

October 26, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Presentation TCT 2021

PCI Phase: Bleeding Avoidance Strategies in the High Bleeding Risk Patient

Presenter: Dominick Angiolillo

November 06, 2021

Presentation TCT 2021

Debate: Follow the Bleeding Risk, Shorten DAPT!

Presenter: Dominick Angiolillo

November 05, 2021

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion, and More

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Noncardiac Surgery in ACS and After PCI: Role of Bridging and Timing to Restart Antiplatelet Therapy

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Switch Therapies/ USE NOACs Instead of Coumadin

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Take Home for Clinicians: DM and STEMI

Presenter: Dominick Angiolillo

September 26, 2019

Presentation TCT 2018

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Renato D. Lopes

September 24, 2018

Presentation TCT 2018

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Yongwhi Park

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Pascal Vranckx

September 24, 2018

Presentation TCT 2018

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Patrick W. Serruys

September 24, 2018

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Advertisement

The Inflammatory Core of Coronary Artery Disease

Debate Con: Never

Optimal Anti-Thrombotic Therapy in Acute MI

Update on Current Treatment Targets for Secondary Prevention

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

PCI Phase: Bleeding Avoidance Strategies in the High Bleeding Risk Patient

Debate: Follow the Bleeding Risk, Shorten DAPT!

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Aspirin Variability, Interactions and Impact of Different Formulations

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion, and More

Noncardiac Surgery in ACS and After PCI: Role of Bridging and Timing to Restart Antiplatelet Therapy

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Switch Therapies/ USE NOACs Instead of Coumadin

Take Home for Clinicians: DM and STEMI

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

GLOBAL LEADERS: First Report of the Results in ACS and Non-ACS Subgroups

GLOBAL LEADERS: A Randomized Trial of Ticagrelor Monotherapy After PCI - Patient-Oriented Clinical Outcomes and Net Adverse Cardiovascular Events

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content